2023-2028 Global and Regional Point-of-Care Infectious Disease Diagnostics/Testing Industry Status and Prospects Professional Market Research Report Standard Version
The global Point-of-Care Infectious Disease Diagnostics/Testing market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Alere
Thermo Fisher Scientific Inc
F. Hoffmann-La Roche Ltd
Siemens Healthineers
BD & Company
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
bioMérieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics
By Types:
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC
By Applications:
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Analysis from 2023 to 2028
1.5.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Point-of-Care Infectious Disease Diagnostics/Testing Industry Impact
Chapter 2 Global Point-of-Care Infectious Disease Diagnostics/Testing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing (Volume and Value) by Type
2.1.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Market Share by Type (2017-2022)
2.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Type (2017-2022)
2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing (Volume and Value) by Application
2.2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Market Share by Application (2017-2022)
2.2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Application (2017-2022)
2.3 Global Point-of-Care Infectious Disease Diagnostics/Testing (Volume and Value) by Regions
2.3.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Regions (2017-2022)
4.2 North America Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.10 South America Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
5.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
5.1.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
5.2 North America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
5.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
5.4 North America Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
5.4.1 United States Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
5.4.2 Canada Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
5.4.3 Mexico Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 6 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
6.1 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
6.1.1 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
6.2 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
6.3 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
6.4 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
6.4.1 China Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
6.4.2 Japan Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
6.4.3 South Korea Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 7 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
7.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
7.1.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
7.2 Europe Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
7.3 Europe Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
7.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
7.4.1 Germany Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.2 UK Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.3 France Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.4 Italy Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.5 Russia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.6 Spain Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.7 Netherlands Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.8 Switzerland Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.9 Poland Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 8 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
8.1 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
8.1.1 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
8.2 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
8.3 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
8.4 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
8.4.1 India Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
8.4.2 Pakistan Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
9.1 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
9.1.1 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
9.2 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
9.3 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
9.4 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
9.4.1 Indonesia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
9.4.2 Thailand Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
9.4.3 Singapore Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
9.4.4 Malaysia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
9.4.5 Philippines Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
9.4.6 Vietnam Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
9.4.7 Myanmar Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 10 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
10.1 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
10.1.1 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
10.2 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
10.3 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
10.4 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
10.4.1 Turkey Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.3 Iran Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.5 Israel Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.6 Iraq Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.7 Qatar Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.8 Kuwait Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.9 Oman Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 11 Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
11.1 Africa Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
11.1.1 Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
11.2 Africa Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
11.3 Africa Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
11.4 Africa Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
11.4.1 Nigeria Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
11.4.2 South Africa Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
11.4.3 Egypt Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
11.4.4 Algeria Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
11.4.5 Morocco Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 12 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
12.1 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
12.2 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
12.3 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
12.4 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
12.4.1 Australia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
12.4.2 New Zealand Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 13 South America Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
13.1 South America Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
13.1.1 South America Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
13.2 South America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
13.3 South America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
13.4 South America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Major Countries
13.4.1 Brazil Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.2 Argentina Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.3 Columbia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.4 Chile Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.5 Venezuela Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.6 Peru Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.8 Ecuador Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Point-of-Care Infectious Disease Diagnostics/Testing Business
14.1 Alere
14.1.1 Alere Company Profile
14.1.2 Alere Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.1.3 Alere Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Thermo Fisher Scientific Inc
14.2.1 Thermo Fisher Scientific Inc Company Profile
14.2.2 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 F. Hoffmann-La Roche Ltd
14.3.1 F. Hoffmann-La Roche Ltd Company Profile
14.3.2 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.3.3 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Siemens Healthineers
14.4.1 Siemens Healthineers Company Profile
14.4.2 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 BD & Company
14.5.1 BD & Company Company Profile
14.5.2 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Chembio Diagnostics Inc.
14.6.1 Chembio Diagnostics Inc. Company Profile
14.6.2 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Trinity Biotech
14.7.1 Trinity Biotech Company Profile
14.7.2 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Cardinal Health
14.8.1 Cardinal Health Company Profile
14.8.2 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Quest Diagnostics Inc.
14.9.1 Quest Diagnostics Inc. Company Profile
14.9.2 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Bio-Rad Labs Inc.
14.10.1 Bio-Rad Labs Inc. Company Profile
14.10.2 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 bioMérieux SA
14.11.1 bioMérieux SA Company Profile
14.11.2 bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Sight Diagnostics Ltd.
14.12.1 Sight Diagnostics Ltd. Company Profile
14.12.2 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Gene POC
14.13.1 Gene POC Company Profile
14.13.2 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Trivitron Healthcare
14.14.1 Trivitron Healthcare Company Profile
14.14.2 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 OJ-Bio Ltd.
14.15.1 OJ-Bio Ltd. Company Profile
14.15.2 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Ortho-Clinical Diagnostics
14.16.1 Ortho-Clinical Diagnostics Company Profile
14.16.2 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Forecast (2023-2028)
15.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Value and Growth Rate Forecast (2023-2028)
15.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Forecast by Type (2023-2028)
15.3.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Forecast by Type (2023-2028)
15.3.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Price Forecast by Type (2023-2028)
15.4 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume Forecast by Application (2023-2028)
15.5 Point-of-Care Infectious Disease Diagnostics/Testing Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Figure Product Picture
Figure North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure United States Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Canada Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Mexico Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure East Asia Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure China Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Japan Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure South Korea Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Germany Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure UK Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure France Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Italy Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Russia Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Spain Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Netherlands Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Switzerland Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Poland Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure South Asia Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure India Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Pakistan Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Bangladesh Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Indonesia Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Thailand Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Singapore Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Malaysia Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Philippines Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Vietnam Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Myanmar Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Middle East Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Turkey Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Saudi Arabia Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Iran Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure United Arab Emirates Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Israel Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Iraq Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Qatar Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Kuwait Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Oman Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Nigeria Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure South Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Egypt Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Algeria Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Algeria Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Oceania Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Australia Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure New Zealand Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Brazil Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Argentina Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Columbia Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Chile Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Venezuela Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Peru Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Puerto Rico Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Ecuador Point-of-Care Infectious Disease Diagnostics/Testing Revenue ($) and Growth Rate (2023-2028)
Figure Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Analysis from 2023 to 2028 by Consumption Volume
Figure Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Analysis from 2023 to 2028 by Value
Table Global Point-of-Care Infectious Disease Diagnostics/Testing Price Trends Analysis from 2023 to 2028
Table Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Market Share by Type (2017-2022)
Table Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Type (2017-2022)
Table Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Market Share by Application (2017-2022)
Table Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Application (2017-2022)
Table Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Market Share by Regions (2017-2022)
Table Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Regions (2017-2022)
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Major Manufacturers Capacity and Total Capacity
Table 2017-2022 Major Manufacturers Capacity Market Share
Table 2017-2022 Major Manufacturers Production and Total Production
Table 2017-2022 Major Manufacturers Production Market Share
Table 2017-2022 Major Manufacturers Revenue and Total Revenue
Table 2017-2022 Major Manufacturers Revenue Market Share
Table 2017-2022 Regional Market Capacity and Market Share
Table 2017-2022 Regional Market Production and Market Share
Table 2017-2022 Regional Market Revenue and Market Share
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|